SLDB
Solid Biosciences Provides Update On SGT-001 Clinical Development Program For Duchenne Muscular Dystrophy
Wednesday, April 18, 2018 1 min read
Key Takeaway: Solid Biosciences Provides Update On SGT-001 Clinical Development Program For Duchenne Muscular Dystrophy
Full Press Release Details
Solid Biosciences Provides Update On SGT-001 Clinical Development Program For Duchenne Muscular Dystrophy.